What is Omeros's price / book?

Omeros (OMER) reported price / book of 16.7× in Q2 2023.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Omeros OMER Price / book

Price / book at other companies

Cullinan Therapeutics, Inc.CGEM

1.5×+0.3×

Nektar TherapeuticsNKTR

3.6×-5.6×

ImmunomeIMNM

4.2×+2.3×

Vor BiopharmaVOR

1.4×0.0×

AnnexonANNX

4×+3.2×

Arcus BiosciencesRCUS

5.2×+3.6×

Other financials

Income statement

See full

Revenue$9.9M—

Gross profit$29.7M—

Operating income-$40.9M-9.2%

Net income$56.1M+268%

EPS (diluted)-$0.59-20.4%

Balance sheet

See full

Cash & equivalents$1.9M-55.3%

Total debt$13.5M-30.3%

Total equity-$63.3M+70.3%

Total assets$286.2M+21.7%

Cash flow

See full

Operating cash flow-$14.5M+59.5%

CapEx--100%

Free cash flow-$14.5M+59.6%

Valuation

See full

Market cap$775.86M+313%

P/S8.6×—

Profitability

See full

Gross margin98.9%—

Operating margin-181.8%—

Net margin-136.6%—

FCF margin-121.6%—

Returns & leverage

See full

Return on equity86.6%—

Debt / equity0.3×-1.1×

Current ratio3×+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

market cap/total stockholders equity=16.7×

Based on the most recent quarter.

The official record: Omeros’s 10-Q, filed August 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Omeros's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Omeros's price / book?: Omeros (OMER) reported price / book of 16.7× in Q2 2023.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.